Insure Your Company Blog
-
Death Panel Accusation Haunts FDA
Paul August 20, 2010
Avastin, a popular cancer treatment drug may have its approval revoked by the FDA after studies have found that the drug may not extend patients lives beyond a month, according to The Daily Telegraph. This [...]
read more